Ponoi Management, LLC Rapt Therapeutics, Inc. Transaction History
Ponoi Management, LLC
- $73.2 Million
- Q3 2022
A detailed history of Ponoi Management, LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Ponoi Management, LLC holds 1,599,417 shares of RAPT stock, worth $3.21 Million. This represents 52.54% of its overall portfolio holdings.
Number of Shares
1,599,417
Previous 1,599,417
-0.0%
Holding current value
$3.21 Million
Previous $29.2 Million
31.84%
% of portfolio
52.54%
Previous 46.09%
Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
125Shares Held
29.1MCall Options Held
905KPut Options Held
592K-
Vanguard Group Inc Valley Forge, PA3.11MShares$6.25 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$5.39 Million11.48% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$4.9 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$3.47 Million0.61% of portfolio
-
Morgan Stanley New York, NY1.18MShares$2.37 Million0.0% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $59.6M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...